TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 24.60
-0.50 (-1.99%)
Sep 5, 2025, 1:50 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 2.72 billion as of September 5, 2025. Its market cap has decreased by -20.30% in one year.
Market Cap
2.72B
Enterprise Value
2.30B
Revenue
15.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.60
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 2.72B, a decrease of -16.23%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 2.72B | -4.55% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | 2.58B | 119.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |